Crohn's disease: trials for referral
463 open trials in the registries we read. Each row links to its registry record.
Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.
Where the open trials are
Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.
400 trials shown · Showing the 400 most recently updated of 463 open trials.
Phase 14 sites
Not yet recruitingGermany
NCT07923383
An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates
Sanofi
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 46 sites
By invitation onlyDenmark
NCT06788340
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
Odense University Hospital
Registry updated 6 Nov 2026
Registry record: ClinicalTrials.govPhase 319 sites
RecruitingAustralia, Brazil, United Kingdom, Mexico, Thailand, Taiwan
NCT07298421
A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
Hoffmann-La Roche
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 21 site
Not yet recruitingUnited States
NCT07225998
Oral N-acetylglucosamine in Crohn's Disease
Johns Hopkins University
Registry updated 5 Nov 2026
Registry record: ClinicalTrials.govPhase 414 sites
RecruitingFrance
NCT07292012
Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govPhase 271 sites
RecruitingBelgium, Brazil, Canada, China, Germany, Hungary
NCT07483099
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Eli Lilly and Company
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govPhase 3182 sites
RecruitingAustria, Belgium, Bulgaria, Brazil, Canada, Czechia
NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Eli Lilly and Company
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govPhase 271 sites
RecruitingBelgium, Brazil, Canada, China, Germany, Hungary
NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Eli Lilly and Company
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govPhase 2231 sites
RecruitingAustria, Australia, Bulgaria, Brazil, Canada, Colombia
NCT06226883
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Registry updated 4 Nov 2026
Registry record: ClinicalTrials.govNo phase51 sites
RecruitingBelgium, United Kingdom, Hungary, Italy, Netherlands, Slovenia
NCT07363044
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease
Alimentiv Inc.
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 220 sites
RecruitingUnited States
NCT07753850
A Study of SL-325 in Crohn's Disease Patients
Shattuck Labs, Inc.
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 41 site
RecruitingUnited States
NCT07654751
A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 3164 sites
RecruitingAustria, Belgium, Canada, China, Czechia, Germany
NCT07499232
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 358 sites
RecruitingArgentina, Australia, Belgium, Brazil, China, Germany
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 3295 sites
RecruitingArgentina, Austria, Australia, Belgium, Brazil, Canada
NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 45 sites
RecruitingChina
NCT07310095
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
Xian-Janssen Pharmaceutical Ltd.
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 385 sites
RecruitingAustria, Australia, Belgium, Brazil, Canada, Spain
NCT05923073
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 2/3399 sites
RecruitingArgentina, Australia, Belgium, Brazil, Canada, Switzerland
NCT07196722
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 337 sites
RecruitingCzechia, France, United Kingdom, Georgia, Hungary, Poland
NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Merck Sharp & Dohme LLC
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 343 sites
RecruitingChina
NCT05837897
A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
Takeda
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 3491 sites
RecruitingAustria, Australia, Belgium, Brazil, Canada, Switzerland
NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Merck Sharp & Dohme LLC
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 1/21 site
RecruitingUnited States
NCT03167437
An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
National Institute of Allergy and Infectious Diseases (NIAID)
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 283 sites
RecruitingAustralia, Belgium, China, Czechia, Germany, Spain
NCT06958536
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Sanofi
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 2206 sites
RecruitingAustralia, Belgium, Bulgaria, Brazil, Canada, Switzerland
NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Takeda
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 413 sites
By invitation onlyUnited States
NCT07686757
INSIGHT-IBD Pragmatic Study
Specialty Networks Research.
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.govPhase 211 sites
RecruitingUnited Kingdom, Serbia, United States
NCT07683325
NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
Agomab Spain S.L.U.
Registry updated 29 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingVietnam
NCT07799428
Bacillus Probiotic Spores in Supporting the Treatment of Chronic Inflammatory Bowel Disease
Anabio R&D
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govNo phase2 sites
RecruitingUnited States
NCT05579392
A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
Rush University Medical Center
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govPhase 4101 sites
RecruitingUnited States
NCT06581328
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Takeda
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govPhase 266 sites
RecruitingCanada, Israel, Japan, Taiwan, United States
NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
AbbVie
Registry updated 27 Oct 2026
Registry record: ClinicalTrials.gov
The same sites as a list
- United States120 open trials
- France71 open trials
- China65 open trials
- Italy48 open trials
- Canada45 open trials
- Belgium41 open trials
- Poland39 open trials
- Germany37 open trials
- Netherlands36 open trials
- Spain35 open trials
- United Kingdom34 open trials
- South Korea27 open trials
- Israel25 open trials
- Czechia24 open trials
- Japan22 open trials
- Hungary20 open trials
- Denmark19 open trials
- Portugal17 open trials
- Australia16 open trials
- Brazil16 open trials
- Austria15 open trials
- Slovakia14 open trials
- Sweden14 open trials
- Taiwan13 open trials
- Romania12 open trials
- Greece12 open trials
- India10 open trials
- Bulgaria10 open trials
- Norway10 open trials
- Türkiye9 open trials
- Serbia9 open trials
- Croatia7 open trials
- Switzerland7 open trials
- Georgia6 open trials
- Lithuania6 open trials
- South Africa5 open trials
- Argentina5 open trials
- Mexico4 open trials
- Ukraine4 open trials
- Chile4 open trials
- Ireland4 open trials
- Thailand3 open trials
- Colombia3 open trials
- Moldova3 open trials
- Latvia3 open trials
- Malaysia3 open trials
- Finland3 open trials
- Egypt3 open trials
- Puerto Rico2 open trials
- Slovenia2 open trials
- Russia2 open trials
- Kazakhstan1 open trial
- Bosnia and Herzegovina1 open trial
- Vietnam1 open trial
- New Zealand1 open trial
- Dominican Republic1 open trial
- Guatemala1 open trial
- United Arab Emirates1 open trial
- Estonia1 open trial
- Singapore1 open trial
- Jordan1 open trial
- Saudi Arabia1 open trial
- Hong Kong1 open trial
- Guadeloupe1 open trial
Who treats this
Institutions with trials or publications in this disease (OpenAlex, registries). Institutions only, no people.
Amsterdam UMC Location University of Amsterdam
Amsterdam, Netherlands
9 trials · 39 publications · ROR
Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
2 trials · 49 publications · ROR
Cincinnati Children's Hospital Medical Center
Cincinnati, United States
8 trials · 30 publications · ROR
Complejo Hospitalario Universitario de Santiago
Santiago de Compostela, Spain
3 trials · 33 publications · ROR
What changed in the last 7 days
Registry facts, one per line, newest first.
Opened for recruitment
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
NCT06788340 · Phase 4 · Denmark
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Completed
NCT05072782 · Phase 4 · Belgium, Spain, France
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Completed
Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis
NCT02412553 · No phase · United States
Source: ClinicalTrials.govStatus changed: Recruiting → Not yet recruiting
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
NCT06788340 · Phase 4 · Denmark
Source: ClinicalTrials.govPhase changed: Phase 4 → Phase 3
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
NCT06227910 · Phase 3 · Austria, Belgium, Brazil, Canada, Switzerland, Czechia
Source: ClinicalTrials.govOpened for recruitment
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
NCT06113913 · Phase 4 · Belgium
Source: ClinicalTrials.govOpened for recruitment
InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
NCT06059989 · Phase 3 · Netherlands
Source: ClinicalTrials.govPhase changed: Phase 4 → Phase 3
InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
NCT06059989 · Phase 3 · Netherlands
Source: ClinicalTrials.govClosed for recruitment
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
NCT05910528 · Phase 2 · Belgium, Bulgaria, Czechia, Germany, Spain, France
Source: ClinicalTrials.govOpened for recruitment
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
NCT05509777 · Phase 3 · Austria, Belgium, Brazil, Canada, Spain, France
Source: ClinicalTrials.govPhase changed: Phase 4 → Phase 3
Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
NCT04997733 · Phase 3 · France
Source: ClinicalTrials.govStatus changed: Recruiting → By invitation only
De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease
NCT04646187 · Phase 4 · Belgium, Spain, Netherlands
Source: ClinicalTrials.govStatus changed: Running, not recruiting → Completed
USTekinumab in Fistulising Perianal Crohn's Disease (USTAP)
NCT04496063 · Phase 4 · France
Source: ClinicalTrials.govOpened for recruitment
MSC Intratissular Injection in Crohn Disease Patients
NCT03901235 · Phase 1/2 · Belgium
Source: ClinicalTrials.govPhase changed: Phase 1 → Phase 2
Fluorescence Imaging of IBD and RA Using Adalimumab-800CW
NCT03938701 · Phase 2 · Netherlands
Source: ClinicalTrials.govClosed for recruitment
InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
NCT06059989 · Phase 3 · Netherlands
Source: ClinicalTrials.govClosed for recruitment
MSC Intratissular Injection in Crohn Disease Patients
NCT03901235 · Phase 1/2 · Belgium
Source: ClinicalTrials.govOpened for recruitment
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
NCT05910528 · Phase 2 · Belgium, Bulgaria, Czechia, Germany, Spain, France
Source: ClinicalTrials.govClosed for recruitment
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
NCT06113913 · Phase 4 · Belgium
Source: ClinicalTrials.gov
Show more
Closed for recruitment
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
NCT05509777 · Phase 3 · Austria, Belgium, Brazil, Canada, Spain, France
Source: ClinicalTrials.govClosed for recruitment
National GMA Post-market Clinical Follow-up Study (GRACE)
NCT05636709 · No phase · Spain
Source: ClinicalTrials.govNew in the registry
Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease
NCT06266663 · No phase · United States
Source: ClinicalTrials.govNew in the registry
Effects of Different Physical Activity Strategies on Disease Activity of IBD Patients
NCT07916493 · No phase
Source: ClinicalTrials.govNew in the registry
TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)
NCT05903066 · No phase · Belgium, France
Source: ClinicalTrials.govPhase changed: No phase → Phase 3
Cellvizio to Evaluate Margins in Crohn's Ileal Disease
NCT05805020 · Phase 3 · France
Source: ClinicalTrials.gov
New reviews, guidelines and randomised trials in PubMed
Guideline
Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru · PubMed
Results card
Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.
No phaseEnded Oct 2026
Completed40 participants
NCT02412553
Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis
Phase 4Ended 15 Oct 2026
Phase 2Ended 15 Oct 2026
No phaseEnded Sept 2026
Paused44 participants
NCT05606419
The Crohn's Disease Exclusion Diet With Early Dairy Introduction vs Partial Enteral Nutrition for Crohn's Disease
Reason given: Study was suspended on September 24 because of funding constraints. At that point, approximately 50 % of the planned participants had enrolled. All data collected to date will be analyzed.
Phase 2Ended 15 Sept 2026
Completed186 participants
NCT06637631
A study to investigate efficacy and safety of SAR441566 in patients with Crohn's disease.
No phaseEnded 10 Sept 2026
Completed238 participants
NCT06587828
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
No phaseEnded 1 Sept 2026
Phase 4Ended 27 Aug 2026
No phaseEnded 26 Aug 2026
Completed366 participants
NCT06266663
Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease
Early Phase 1Ended 15 Aug 2026
Phase 2Ended 15 Aug 2026
Withdrawn before start0 participants
NCT05471492
Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease
Reason given: Trial not started; change in Sponsor, a new trial to be registered by the new Sponsor
No phaseEnded 31 Jul 2026
Completed673 participants
NCT04535882
Effectiveness of Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD
No phaseEnded 5 Jul 2026
No phaseEnded 30 Jun 2026
Completed1006 participants
NCT05626088
A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil
No phaseEnded 30 Jun 2026
Completed292 participants
NCT04827368
Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease
Phase 4Ended 29 Jun 2026
No phaseEnded 24 Jun 2026
Completed64 participants
NCT06094608
IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms
Phase 2Ended 20 Jun 2026
Completed103 participants
NCT05843578
STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease
Phase 2Ended 19 Jun 2026
Completed63 participants
2022-502789-26-01
A clinical trial to assess the safety and effects of AGMB-129 compared to placebo in patients with fibrostenotic Crohn’s disease.
No phaseEnded 11 Jun 2026
Withdrawn before start0 participants
NCT06822686
Autologous Stem Cells in the Management of Fistulating Perianal Crohn's Disease
Reason given: Unable to obtain theatre access to carry out the trial.
Show more
No phaseEnded 6 Jun 2026
No phaseEnded 5 Jun 2026
Completed10 participants
NCT07508592
Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery
Phase 3Ended 29 May 2026
Phase 1/2Ended 28 May 2026
Completed128 participants
NCT03847467
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
No phaseEnded 1 May 2026
Completed3 participants
NCT07597577
Upadacitinib in Isolated Small Bowel Versus Non-Small Bowel Crohn's Disease
Phase 3Ended Apr 2026
Withdrawn before start0 participants
NCT04643483
A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease
Reason given: Sponsor decision
No phaseEnded 30 Apr 2026
Completed437 participants
NCT07757217
Artificial Intelligence-Based Classification and Prognostic Prediction in Small Bowel Crohn's Disease
No phaseEnded 20 Apr 2026
Stopped early29 participants
NCT05333978
Optoacoustic Detection of Inflammation Using MSOT Device
Reason given: Administrative Reasons
No phaseEnded 31 Mar 2026
Completed84 participants
NCT07697547
Efficacy and Safety of Low-Dose Upadacitinib Combined With Ustekinumab in the Treatment of Refractory Crohn's Disease
Phase 1Ended 27 Mar 2026
No phaseEnded 25 Mar 2026
Completed335 participants
NCT04002180
Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]
No phaseEnded 1 Mar 2026
Completed60 participants
NCT07694362
Narrow Band Imaging Versus Artificial Intelligence for Colonic Surveillance in Inflammatory Bowel Disease
No phaseEnded 25 Feb 2026
No phaseEnded 15 Feb 2026
Phase 4Ended 5 Feb 2026
Completed10 participants
NCT06346288
A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease
No phaseEnded 20 Jan 2026
Completed156 participants
NCT07600255
Assessment on the Deep Remission Rate and Its Influencing Factors of Individualized Ustekinumab Therapy in Patients With Crohn's Disease
No phaseEnded 1 Jan 2026
Phase 3Ended 1 Jan 2026
Withdrawn before start0 participants
NCT05104229
SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery
Reason given: Limited Resources
No phaseEnded 1 Jan 2026
No phaseEnded 31 Dec 2025
Withdrawn before start0 participants
NCT04129723
Stopping Biological Therapy in PCD Study
Reason given: No suitable case identified
Phase 4Ended 30 Dec 2025
No phaseEnded 9 Dec 2025
Phase 1Ended 1 Dec 2025
Withdrawn before start0 participants
NCT03747718
Randomized Trial Comparing Single vs. Maintenance Fecal Microbiota Transplant for Refractory Crohn's Disease in Children
Reason given: Funding
No phaseEnded 1 Dec 2025
Completed38 participants
NCT06381518
Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease
No phaseEnded 30 Nov 2025
Completed250 participants
NCT06526234
Performance of Non-injected MR Enterography Compared to a Conventional MR Enterography Protocol With Contrast Agent Injection
Phase 2Ended 18 Nov 2025
Completed3 participants
NCT03983837
Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease
Phase 2Ended 3 Nov 2025
No phaseEnded 31 Oct 2025
No phaseEnded 30 Oct 2025
No phaseEnded 24 Oct 2025
No phaseEnded 15 Oct 2025
Completed803 participants
NCT06646757
Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome Disability
No phaseEnded 9 Oct 2025
Completed22 participants
NCT06575660
Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease
No phaseEnded 5 Oct 2025
No phaseEnded 30 Sept 2025
Completed55 participants
NCT05651542
A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease
No phaseEnded 19 Sept 2025
Phase 3Ended 12 Sept 2025
Completed38 participants
NCT04397263
A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
No phaseEnded 30 Aug 2025
Completed150 participants
NCT07167745
Tracking the Natural Course of Silent Small Bowel Narrowing in Adults With Crohn's Disease
No phaseEnded 25 Aug 2025
No phaseEnded 15 Aug 2025
Completed58 participants
NCT07211789
Real World Evidence Study With Restrictive Diet and Otral Nutritional Supplementation on Pediatric Patients With Active Chron Disease
No phaseEnded Jul 2025
Withdrawn before start0 participants
NCT06030882
Improving Patient Outcomes Through the Implementation of an IBD Biologic Care Pathway
Reason given: Intervention (Biologic care pathway) was implemented outside of the context of a research study at our care centre, the QEII, as quality improvement. It became infeasible to consent all physicians to use the tool, and carry out this study.
Not medical advice. fetched 9 Nov 2026